Evidence map›Paper›PMID 34613632›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2021

The pseudoprotease iRhom1 controls ectodomain shedding of membrane proteins in the nervous system.

Johanna Tüshaus, Stephan A Müller, Joshua Shrouder, Martina Arends, Mikael Simons, Nikolaus Plesnila, Carl P Blobel, Stefan F Lichtenthaler

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Johanna TüshausGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Stephan A MüllerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Joshua ShrouderInstitute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig-Maximilians-University Munich, Munich, Germany.
Martina ArendsGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Mikael SimonsGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Nikolaus PlesnilaInstitute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig-Maximilians-University Munich, Munich, Germany.
Carl P BlobelDepartment of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, New York, USA.
Stefan F LichtenthalerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Technical University of Munich · DEGerman Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DEMunich Cluster for Systems Neurology · DEWeill Cornell Medicine · US

Funding

Role of iRhoms and ADAM17 in EGFR and TNFalpha signalingR35GM134907 · NIGMS · HOSPITAL FOR SPECIAL SURGERY · PI BLOBEL, CARL PETER · 2020 to 2024
$2.0M
NIGMS NIH HHS R35 GM134907
6 · The paper itself

Abstract

Proteolytic ectodomain shedding of membrane proteins is a fundamental mechanism to control the communication between cells and their environment. A key protease for membrane protein shedding is ADAM17, which requires a non-proteolytic subunit, either inactive Rhomboid 1 (iRhom1) or iRhom2 for its activity. While iRhom1 and iRhom2 are co-expressed in most tissues and appear to have largely redundant functions, the brain is an organ with predominant expression of iRhom1. Yet, little is known about the spatio-temporal expression of iRhom1 in mammalian brain and about its function in controlling membrane protein shedding in the nervous system. Here, we demonstrate that iRhom1 is expressed in mouse brain from the prenatal stage to adulthood with a peak in early postnatal development. In the adult mouse brain iRhom1 was widely expressed, including in cortex, hippocampus, olfactory bulb, and cerebellum. Proteomic analysis of the secretome of primary neurons using the hiSPECS method and of cerebrospinal fluid, obtained from iRhom1-deficient and control mice, identified several membrane proteins that require iRhom1 for their shedding in vitro or in vivo. One of these proteins was 'multiple-EGF-like-domains protein 10' (MEGF10), a phagocytic receptor in the brain that is linked to the removal of amyloid β and apoptotic neurons. MEGF10 was further validated as an ADAM17 substrate using ADAM17-deficient mouse embryonic fibroblasts. Taken together, this study discovers a role for iRhom1 in controlling membrane protein shedding in the mouse brain, establishes MEGF10 as an iRhom1-dependent ADAM17 substrate and demonstrates that iRhom1 is widely expressed in murine brain.

Indexed as

ADAM17 ProteinAnimalsBrainMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMouse Embryonic Stem CellsADAM17 ProteinAdam17 protein, mouseiRhom1 protein, mouseMegf10 protein, mouseMembrane ProteinsADAM17CSFhiSPECSiRhom1myelinationsecretome

Identifiers

PMID34613632
PMCPMC8624807
OpenAlexW3202237787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.